Research
Hormonal
Discontinuation of semaglutide leads to significant weight regain ('semaglutide rebound'), with studies showing approximately two-thirds of lost weight is regained within one year.
If you stop taking semaglutide, expect to regain about two-thirds of the weight you lost within a year. This 'rebound' effect is common. Plan for sustainable lifestyle changes or discuss long-term management strategies with your doctor before stopping.
GoodSupportsHIGH confidence
A study conducted on 327 non-diabetic individuals who received a once-weekly 2.4 mg dose of semaglutide found that participants regained two-thirds of their lost weight within 1 year of stopping the medication.
Why this rating
Cites a specific study on 327 non-diabetic individuals, providing quantitative data on weight regain.
Source
Semaglutide and the skin: A brief review of dermatologic implications
Arisha Salam et al. · Cosmoderma · 2025
DOI 10.25259/csdm_97_2025
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →